Pluriomics Stem Cell technology

Advances in Cell Based Screening 2017


Location: AstraZeneca, Gothenburg, Sweden
Date: May 10-11, 2017 

Pluriomics will attend the 2nd ELRIG bi-annual conference on Advances in Cell Based Screening in Drug Discovery to be held on the 10th and 11th of May 2017 at AstraZeneca in Gothenburg.

This interactive 2-day event will host leading scientists from academia and industry, coming together to discuss the latest developments in cell based screening in drug discovery.

Don’t miss the opportunity to meet Dr. Farbod Famili, Assay Development Scientist at Pluriomics, and learn about Pluriomics’ high throughput applications using Pluricyte® Cardiomyocytes in various (electro)physiology-based assays for the prediction of cardiotoxicity at different cellular levels during drug discovery.

Farbod will also present a poster entitled: “Multiparametric assessment of the effects of chemotherapeutic drugs on the (electro)physiology of Pluricyte® Cardiomyocytes”.

View the programme here.